Phathom Pharmaceuticals, Inc. (PHAT)
11.34
+0.20
(+1.80%)
USD |
NASDAQ |
Apr 02, 16:00
11.34
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals EPS Diluted (Quarterly) : -0.2865 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Replimune Group, Inc. | -0.7694 |
| ANI Pharmaceuticals, Inc. | 1.172 |
| MannKind Corp. | -0.0519 |
| Ocugen, Inc. | -0.0567 |
| Vanda Pharmaceuticals, Inc. | -2.389 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.15M |
| Revenue (Quarterly) | 57.58M |
| Total Expenses (Quarterly) | 78.73M |
| Enterprise Value | 1.353B |
| Gross Profit Margin (Quarterly) | 86.72% |
| Profit Margin (Quarterly) | -36.73% |
| Earnings Yield | -26.45% |
| Normalized Earnings Yield | -26.45 |